Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
3,685
3,685 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- BNT3214PM8102Phase 21 trial
BioNTech SE · Advanced Solid Tumor Cancer
- BNT329Phase 21 trial
BioNTech SE · Advanced Solid Cancers
- BO-112Phase 21 trial
Highlight Therapeutics · Basal Cell Carcinoma
- BosmolisibBR101801Phase 21 trial
Boryung Pharmaceutical Co., Ltd · Peripheral T Cell Lymphoma
- BP1001Phase 21 trial
Bio-Path Holdings, Inc. · Acute Myeloid Leukemia (AML)
- BPC-2001KRN-7000Phase 21 trial
BioPhoenix Co., Ltd. · Graft -Versus-host-disease, aGVHD, Haploidentical Stem Cell Transplantation
- BPI-361175Phase 21 trial
Xcovery Holdings, Inc. · Non-small Cell Lung Carcinoma
- BPI-572270Phase 21 trial
Betta Pharmaceuticals Co., Ltd. · Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma (PDAC)
- BPM31510Phase 21 trial
BPGbio · Glioblastoma, Glioblastoma Multiforme
- BPR-6023021Phase 21 trial
Chengdu Syncor Pharmaceutical Co., Ltd. · Metastatic Solid Tumors
- BR1400-1Phase 21 trial
Boryung Pharmaceutical Co., Ltd · Essential Hypertension
- BR1400-2Phase 21 trial
Boryung Pharmaceutical Co., Ltd · Essential Hypertension
- BR1400-3Phase 21 trial
Boryung Pharmaceutical Co., Ltd · Essential Hypertension
- BR1400-4Phase 21 trial
Boryung Pharmaceutical Co., Ltd · Essential Hypertension
- BR1400-5Phase 21 trial
Boryung Pharmaceutical Co., Ltd · Essential Hypertension
- BR1400-APhase 21 trial
Boryung Pharmaceutical Co., Ltd · Essential Hypertension
- BR1400-BPhase 21 trial
Boryung Pharmaceutical Co., Ltd · Essential Hypertension
- BR1400-CPhase 21 trial
Boryung Pharmaceutical Co., Ltd · Essential Hypertension
- BR2251Phase 21 trial
BioRay Pharmaceutical Co., Ltd. · Gout and Hyperuricemia
- BR5402APhase 21 trial
Boryung Pharmaceutical Co., Ltd · Schizophrenia
- BR5402A-1Phase 21 trial
Boryung Pharmaceutical Co., Ltd · Schizophrenia
- BR5402BPhase 21 trial
Boryung Pharmaceutical Co., Ltd · Schizophrenia
- BR5402B-1Phase 21 trial
Boryung Pharmaceutical Co., Ltd · Schizophrenia
- BR5402CPhase 21 trial
Boryung Pharmaceutical Co., Ltd · Schizophrenia
- BR5402C-1Phase 21 trial
Boryung Pharmaceutical Co., Ltd · Schizophrenia
- BR5402DPhase 21 trial
Boryung Pharmaceutical Co., Ltd · Schizophrenia
- BR5402D-1Phase 21 trial
Boryung Pharmaceutical Co., Ltd · Schizophrenia
- BriquilimabJSP191Phase 21 trial
Jasper Therapeutics, Inc. · Chronic Spontaneous Urticaria
- BRL-101Phase 21 trial
Bioray Laboratories · Beta-Thalassemia
- BRM421Phase 21 trial
BRIM Biotechnology Inc. · Dry Eye Disease (DED), Keratoconjunctivitis Sicca
- BRTX-100Phase 21 trial
BioRestorative Therapies · Lumbar Disc Disease
- BRX011Phase 21 trial
Biojiva LLC · Geographic Atrophy
- BRY812Phase 21 trial
BioRay Pharmaceutical Co., Ltd. · Advanced Gynecological Malignancies
- BS006Phase 21 trial
Binhui Biopharmaceutical Co., Ltd. · Solid Tumor
- BT02Phase 21 trial
Biotroy Therapeutics · Relapsed or Refractory Hematologic Malignancies, Leukemia, Lymphoma
- BTV100Phase 21 trial
BioTheraVision, Inc. · Dry Eye
- BTZ-043Phase 21 trial
GSK · Tuberculosis
- BW-00112Phase 21 trial
Shanghai Argo Biopharmaceutical Co., Ltd. · Mixed Dyslipidemia
- BW-20805Phase 21 trial
Shanghai Argo Biopharmaceutical Co., Ltd. · Hereditary Angioedema (HAE)
- BX004Combination of nebulized bacteriophages targeting Pseudomonas aeruginosaPhase 21 trial
BiomX Ltd · Chronic Pseudomonas Aeruginosa Infection, Cystic Fibrosis (CF)
- BXQ-350SapC-DOPSPhase 21 trial
Bexion Pharmaceuticals, Inc. · Metastatic Colorectal Carcinoma, Neuropathy
- BZ371APhase 21 trial
Biozeus Biopharmaceutical S.A. · Female Sexual Arousal Disorder, Female Sexual Dysfunction (FSD)
- C019199Phase 21 trial
Fujian Haixi Pharmaceuticals Co., Ltd. · Solid Tumor
- CAL02Phase 21 trial
Eagle Pharmaceuticals, Inc. · Pneumonia, Bacterial
- CAL101Phase 21 trial
Calluna Pharma AS · Idiopathic Pulmonary Fibrosis
- CAN016Phase 21 trial
Canwell Biotech Limited · Patients With Advanced Solid Tumors
- CAP256V2LSPhase 21 trial
Gilead Sciences · HIV-1-infection
- CART84Phase 21 trial
Gyala Therapeutics · Acute Myeloblastic Leukaemia, Leukemia, T-Cell
- CasdozokitugCHS-388Phase 21 trial
Coherus Oncology, Inc. · Hepatocellular Carcinoma
- CB03-154Phase 21 trial
Shanghai Zhimeng Biopharma, Inc. · Focal Epilepsy
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.